ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

An artificial intelligence method to assess the tumor microenvironment with treatment outcomes for gastric cancer patients after gastrectomy

Chen, Tao*; Li, Xunjun; Mao, Qingyi; Wang, Yiyun; Li, Hanyi; Wang, Chen; Shen, Yuyang; Guo, Erjia; He, Qinglie; Tian, Jie; Zhu, Mansheng; Wu, Jing; Liang, Weiqi; Liu, Hao; Yu, Jiang; Li, Guoxin*南方医科大学; 1
Journal of Translational Medicine2022-2-21DOI: 10.1186/s12967-022-03298-7
6被引22阅读
引用收藏
分享

摘要

Background The tumor microenvironment (TME) plays an important role in the occurrence and development of gastric cancer (GC) and is widely used to assess the treatment outcomes of GC patients. Immunohistochemistry (IHC) and gene sequencing are the main analysis methods for the TME but are limited due to the subjectivity of observers, the high cost of equipment and the need for professional analysts. Methods The ImmunoScore (IS) was developed in the TCGA cohort and validated in GEO cohorts. The Radiomic ImmunoScore (RIS) was developed in the TCGA cohort and validated in the Nanfang cohort. A nomogram was developed and validated in the Nanfang cohort based on RIS and clinical features. Results For IS, the area under the curves (AUCs) were 0.798 for 2-year overall survival (OS) and 0.873 for 4-year overall survival. For RIS, in the TCGA cohort, the AUCs distinguishing High-IS or Low-IS and predicting prognosis were 0.85 and 0.81, respectively; in the Nanfang cohort, the AUC predicting prognosis was 0.72. The nomogram performed better than the TNM staging system according to the ROC curve (all P < 0.01). Patients with TNM stage II and III in the High-nomogram group were more likely to benefit from adjuvant chemotherapy than Low-nomogram group patients. Conclusions The RIS and the nomogram can be used to assess the TME, prognosis and adjuvant chemotherapy benefit of GC patients after radical gastrectomy and are valuable additions to the current TNM staging system. High-nomogram GC patients may benefit more from adjuvant chemotherapy than Low-nomogram GC patients.

学科与关键词

关键词
Gastric cancer (GC)Tumor microenvironment (TME)ImmunoScore (IS)Radiomic ImmunoScore (RIS)Artificial intelligence (AI)
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Journal of Translational Medicine
发表日期
2022-02-21
卷期
第 20 卷, 第 1 期
页码
100
DOI
10.1186/s12967-022-03298-7
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Cancer [2020B121201004]; Guangdong Natural Science Foundation General Project [2019A1515011520]; Guangdong Natural Science Foundation Outstanding Youth Project [2021B1515020055]; Guangdong Provincial Major Talents Project [2019JC05Y361]

作者

  • C

    Chen, Tao (通讯) (第一作者)

    1 · southern med univ

  • L

    Li, Xunjun

    1 · southern med univ

查看全部 16 位作者收起作者
  • M

    Mao, Qingyi

    1 · southern med univ

  • W

    Wang, Yiyun

    1 · southern med univ

  • L

    Li, Hanyi

    southern med univ

  • W

    Wang, Chen

    southern med univ

  • S

    Shen, Yuyang

    southern med univ

  • G

    Guo, Erjia

    southern med univ

  • H

    He, Qinglie

    1 · southern med univ

  • T

    Tian, Jie

    1 · southern med univ

  • Z

    Zhu, Mansheng

    1 · southern med univ

  • W

    Wu, Jing

    1 · southern med univ

  • L

    Liang, Weiqi

    1 · southern med univ

  • L

    Liu, Hao

    1 · southern med univ

  • Y

    Yu, Jiang

    1 · southern med univ

  • L

    Li, Guoxin (通讯)

    1 · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417